Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals - 17 Year Stock Price History | MDGL

Historical daily share price chart and data for Madrigal Pharmaceuticals since 2007 adjusted for splits and dividends. The latest closing stock price for Madrigal Pharmaceuticals as of April 22, 2024 is 213.49.
  • The all-time high Madrigal Pharmaceuticals stock closing price was 409.85 on January 28, 2013.
  • The Madrigal Pharmaceuticals 52-week high stock price is 322.67, which is 51.1% above the current share price.
  • The Madrigal Pharmaceuticals 52-week low stock price is 119.76, which is 43.9% below the current share price.
  • The average Madrigal Pharmaceuticals stock price for the last 52 weeks is 215.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Madrigal Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 235.9479 226.8600 283.2300 171.3700 213.4900 -7.73%
2023 226.2730 285.4200 312.0000 120.4000 231.3800 -20.28%
2022 81.2453 90.1200 296.5400 55.8900 290.2500 242.52%
2021 100.6191 109.7600 137.5900 72.3400 84.7400 -23.77%
2020 103.2904 90.6800 133.7000 60.1300 111.1700 22.02%
2019 105.3256 111.1900 143.8400 84.2800 91.1100 -19.17%
2018 176.6024 97.4200 313.9000 93.3500 112.7200 22.80%
2017 26.8424 15.9600 97.3700 13.1100 91.7900 516.04%
2016 11.5455 11.5535 17.6600 6.5450 14.9000 20.94%
2015 67.0312 100.4501 106.0501 10.7310 12.3200 -86.72%
2014 145.7918 184.1002 245.3502 91.0001 92.7501 -49.43%
2013 247.8982 337.4003 409.8504 132.3001 183.4002 -41.91%
2012 217.5373 171.1502 340.2003 129.8501 315.7003 93.15%
2011 163.8068 216.6502 239.4002 107.8001 163.4502 -23.69%
2010 137.1362 193.2002 222.9502 90.3001 214.2002 20.95%
2009 132.5099 215.9502 317.8003 47.6000 177.1002 -17.32%
2008 249.5645 222.2502 347.2003 155.0502 214.2002 -8.66%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.219B $0.000B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.003B 27.54
Chugai Pharmaceutical (CHGCY) Japan $52.278B 22.70
Takeda Pharmaceutical (TAK) Japan $41.902B 6.79
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.192B 24.36
Shionogi (SGIOY) Japan $14.152B 12.24
Sandoz Group AG (SDZNY) Switzerland $13.930B 0.00
Neurocrine Biosciences (NBIX) United States $13.135B 54.54
United Therapeutics (UTHR) United States $11.197B 11.99
Catalent (CTLT) United States $10.040B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.926B 7.02
Ionis Pharmaceuticals (IONS) United States $5.929B 0.00
Revolution Medicines (RVMD) United States $5.751B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.991B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 0.00
Indivior (INDV) United States $2.554B 11.87
Evotec AG (EVO) Germany $2.505B 0.00
Summit Therapeutics (SMMT) United States $2.456B 0.00
Corcept Therapeutics (CORT) United States $2.389B 24.16
Dyne Therapeutics (DYN) United States $2.056B 0.00
PTC Therapeutics (PTCT) United States $1.940B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.786B 18.45
NewAmsterdam Pharma (NAMS) Netherlands $1.779B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.725B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.664B 9.85
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.570B 0.00
Ardelyx (ARDX) United States $1.508B 0.00
4D Molecular Therapeutics (FDMT) United States $1.292B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.240B 11.65
Pacira BioSciences (PCRX) United States $1.221B 12.15
Soleno Therapeutics (SLNO) United States $1.217B 0.00
Collegium Pharmaceutical (COLL) United States $1.139B 7.01
Xencor (XNCR) United States $1.123B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.060B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.913B 0.00
Cronos Group (CRON) Canada $0.905B 0.00
Cassava Sciences (SAVA) United States $0.849B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.37
ARS Pharmaceuticals (SPRY) United States $0.817B 0.00
Enliven Therapeutics (ELVN) United States $0.809B 0.00
Sage Therapeutics (SAGE) United States $0.801B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
Ocular Therapeutix (OCUL) United States $0.776B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.722B 0.00
Silence Therapeutics (SLN) United Kingdom $0.678B 0.00
Savara (SVRA) United States $0.664B 0.00
Siga Technologies (SIGA) United States $0.593B 8.78
Lyell Immunopharma (LYEL) United States $0.567B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.557B 0.00
Verve Therapeutics (VERV) United States $0.555B 0.00
OmniAb (OABI) United States $0.547B 0.00
Korro Bio (KRRO) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.513B 0.00
Altimmune (ALT) United States $0.490B 0.00
KalVista Pharmaceuticals (KALV) United States $0.488B 0.00
ProKidney (PROK) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.454B 0.00
Larimar Therapeutics (LRMR) United States $0.417B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.397B 0.00
Heron Therapeutics (HRTX) United States $0.397B 0.00
Tourmaline Bio (TRML) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.383B 72.50
Harrow (HROW) United States $0.370B 0.00
Esperion Therapeutics (ESPR) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.31
Bioventus (BVS) United States $0.355B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Nanobiotix S.A (NBTX) France $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.242B 0.00
Telomir Pharmaceuticals (TELO) United States $0.236B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.213B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 13.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.67
GlycoMimetics (GLYC) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.120B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
OptiNose (OPTN) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.095B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.073B 5.95
Journey Medical (DERM) United States $0.069B 0.00
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
CERo Therapeutics Holdings (CERO) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
TherapeuticsMD (TXMD) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.11